Idorsia logo

Idorsia

Europe, Basel-Landschaft, Switzerland, Allschwil

Description

The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients.

Investor Profile

Idorsia has made 2 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • Switzerland (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Idorsia frequently co-invest with?

Waypoint Capital
Europe, Geneve, Switzerland, Genève
Co-Investments: 1
Highbridge Capital Management
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Idorsia?

Santhera Pharmaceuticals

Liestal, Basel-Landschaft, Switzerland

Santhera Pharmaceuticals develops and markets pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquityJan 10, 2023
Amount Raised: $5,421,512
Santhera Pharmaceuticals

Liestal, Basel-Landschaft, Switzerland

Santhera Pharmaceuticals develops and markets pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquitySep 20, 2021
Amount Raised: $21,557,648